Dynamics of Human Immunodeficiency Virus Transcription: P-TEFb Phosphorylates RD and Dissociates Negative Effectors from the Transactivation Response Element

REFERENCES

• Adams, M., Sharmeen L., Kimpton J., Romeo J. M., Garcia J. V., Peterlin B. M., Groudine M., and Emerman M.. 1994. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 91:3862–3866.
   PubMedGoogle Scholar
• Barboric, M., Nissen R. M., Kanazawa S., Jabrane-Ferrat N., and Peterlin B. M.. 2001. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8:327–337.
   PubMed Web of Science ®Google Scholar
• Bourgeois, C. F., Kim Y. K., Churcher M. J., West M. J., and Karn J.. 2002. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences. Mol. Cell. Biol. 22:1079–1093.
   PubMed Web of Science ®Google Scholar
• Chao, S. H., Fujinaga K., Marion J. E., Taube R., Sausville E. A., Senderowicz A. M., Peterlin B. M., and Price D. H.. 2000. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem. 275:28345–28348.
   PubMed Web of Science ®Google Scholar
• Eberhardy, S. R., and Farnham P. J.. 2001. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem. 276:48562–48571.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., Cujec T. P., Peng J., Garriga J., Price D. H., Grana X., and Peterlin B. M.. 1998. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:7154–7159.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., Irwin D., Taube R., Zhang F., Geyer M., and Peterlin B. M.. 2002. A minimal chimera of human cyclin T1 and Tat binds TAR and activates human immunodeficiency virus transcription in murine cells. J. Virol. 76:12934–12939.
   PubMedGoogle Scholar
• Fujinaga, K., Taube R., Wimmer J., Cujec T. P., and Peterlin B. M.. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96:1285–1290.
   PubMed Web of Science ®Google Scholar
• Greenblatt, J., Nodwell J. R., and Mason S. W.. 1993. Transcriptional antitermination. Nature 364:401–406.
   PubMed Web of Science ®Google Scholar
• Ivanov, D., Kwak Y. T., Guo J., and Gaynor R. B.. 2000. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20:2970–2983.
   PubMed Web of Science ®Google Scholar
• Kanazawa, S., Okamoto T., and Peterlin B. M.. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12:61–70.
   PubMedGoogle Scholar
• Kao, S. Y., Calman A. F., Luciw P. A., and Peterlin B. M.. 1987. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489–493.
   PubMed Web of Science ®Google Scholar
• Lee, D. K., Duan H. O., and Chang C.. 2001. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J. Biol. Chem. 276:9978–9984.
   PubMed Web of Science ®Google Scholar
• Lin, X., Irwin D., Kanazawa S., Huang L., Romeo J., Yen T. S., and Peterlin B. M.. 2003. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J. Virol. 77:8227–8236.
   PubMed Web of Science ®Google Scholar
• Mancebo, H. S., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., and Flores O.. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633–2644.
   PubMed Web of Science ®Google Scholar
• Nagai, K., Oubridge C., Jessen T. H., Li J., and Evans P. R.. 1990. Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A. Nature 348:515–520.
   PubMed Web of Science ®Google Scholar
• Narita, T., Yamaguchi Y., Yano K., Sugimoto S., Chanarat S., Wada T., Kim D. K., Hasegawa J., Omori M., Inukai N., Endoh M., Yamada T., and Handa H.. 2003. Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol. Cell. Biol. 23:1863–1873.
   PubMed Web of Science ®Google Scholar
• Ping, Y. H., and Rana T. M.. 2001. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276:12951–12958.
   PubMed Web of Science ®Google Scholar
• Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2629–2634.
   PubMed Web of Science ®Google Scholar
• Simone, C., Stiegler P., Bagella L., Pucci B., Bellan C., De Falco G., De Luca A., Guanti G., Puri P. L., and Giordano A.. 2002. Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene 21:4137–4148.
   PubMed Web of Science ®Google Scholar
• Taube, R., Fujinaga K., Irwin D., Wimmer J., Geyer M., and Peterlin B. M.. 2000. Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J. Virol. 74:892–898.
   PubMedGoogle Scholar
• Taube, R., Fujinaga K., Wimmer J., Barboric M., and Peterlin B. M.. 1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264:245–253.
   PubMed Web of Science ®Google Scholar
• Taube, R., Lin X., Irwin D., Fujinaga K., and Peterlin B. M.. 2002. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell. Biol. 22:321–331.
   PubMed Web of Science ®Google Scholar
• Tiley, L. S., Madore S. J., Malim M. H., and Cullen B. R.. 1992. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev. 6:2077–2087.
   PubMedGoogle Scholar
• Wada, T., Orphanides G., Hasegawa J., Kim D. K., Shima D., Yamaguchi Y., Fukuda A., Hisatake K., Oh S., Reinberg D., and Handa H.. 2000. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH. Mol. Cell. 5:1067–1072.
   PubMed Web of Science ®Google Scholar
• Wada, T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S., Sugimoto S., Yano K., Hartzog G. A., Winston F., Buratowski S., and Handa H.. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12:343–356.
   PubMed Web of Science ®Google Scholar
• Wada, T., Takagi T., Yamaguchi Y., Watanabe D., and Handa H.. 1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17:7395–7403.
   PubMed Web of Science ®Google Scholar
• Wei, P., Garber M. E., Fang S. M., Fischer W. H., and Jones K. A.. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451–462.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., Filipovska J., Yano K., Furuya A., Inukai N., Narita T., Wada T., Sugimoto S., Konarska M. M., and Handa H.. 2001. Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science 293:124–127.
   PubMedGoogle Scholar
• Yamaguchi, Y., Inukai N., Narita T., Wada T., and Handa H.. 2002. Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol. Cell. Biol. 22:2918–2927.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S., Hasegawa J., and Handa H.. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97:41–51.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., and Price D. H.. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:2622–2632.
   PubMed Web of Science ®Google Scholar